CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,708 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 277,725 shares (option exercise)
- 4 Exercise or conversion Director acquired 324,012 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 15,429 shares (option exercise)
- 4 Exercise or conversion Director acquired 108,010 shares (option exercise)
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
- 3/A Insider 3/A
- 4 Gift Director gave 16,000 shares (gift)
- 4 Gift Director gave 18,511 shares (gift)
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 3,265 shares at an average $15.33 ($50,043)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chairman and CEO bought 450,000 shares at $23.00 ($10,350,000)
- 4 Open-market sale Director sold 450,000 shares at $23.00 ($10,350,000)
- 3 Insider Initial Statement of Ownership
Page 12 of 13 · 251 filings